ACACIA RESEARCH CORP's gross profit margin for the third quarter of its fiscal year 2015 has significantly decreased when compared to the same period a year ago. Sales and net income fell significantly, underperforming compared to the average company in its industry. ACACIA RESEARCH CORP is extremely liquid. Currently, the Quick Ratio is 6.78 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has decreased by 14.26% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY15||Q3 FY14|
|Net Sales ($mil)||12.99||37.19|
|Net Income ($mil)||-27.31||-12.42|
|Balance Sheet||Q3 FY15||Q3 FY14|
|Cash & Equiv. ($mil)||168.5||226.72|
|Total Assets ($mil)||467.65||548.92|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q3 FY15||Q3 FY14|
|Gross Profit Margin||-74.1||6.73|
|Return on Assets||-12.9||-15.14|
|Return on Equity||-14.03||-16.57|
|Debt||Q3 FY15||Q3 FY14|
|Share Data||Q3 FY15||Q3 FY14|
|Shares outstanding (mil)||50.75||50.11|
|Div / share||0.13||0.13|
|Book value / share||8.47||10.01|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||787218.0||503997.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 0.44 indicates a significant discount versus the S&P 500 average of 2.51 and a significant discount versus the industry average of 5.05. The price-to-sales ratio is similar to the S&P 500 average, but it is significantly below the industry average, indicating a discount. After reviewing these and other key valuation criteria, ACACIA RESEARCH CORP proves to trade at a discount to investment alternatives within the industry.
|ACTG NM||Peers 27.18||ACTG NM||Peers 14.60|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
ACTG's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
ACTG's P/CF is negative making the measure meaningless.
|ACTG 18.75||Peers 18.90||ACTG NA||Peers 0.74|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
ACTG is trading at a premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|ACTG 0.44||Peers 5.05||ACTG 28.33||Peers 19.99|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
ACTG is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
ACTG is expected to have an earnings growth rate that significantly exceeds its peers.
|ACTG 1.61||Peers 3.00||ACTG 3.18||Peers 7.80|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ACTG is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
ACTG significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.